GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gilead Sciences Inc (MIL:1GILD) » Definitions » Other Gross PPE

Gilead Sciences (MIL:1GILD) Other Gross PPE : €1,052 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Gilead Sciences Other Gross PPE?

Gilead Sciences's Other Gross PPE for the quarter that ended in Dec. 2023 was €1,052 Mil.

Gilead Sciences's quarterly Other Gross PPE increased from Jun. 2023 (€5,113 Mil) to Sep. 2023 (€5,221 Mil) but then declined from Sep. 2023 (€5,221 Mil) to Dec. 2023 (€1,052 Mil).

Gilead Sciences's annual Other Gross PPE increased from Dec. 2021 (€843 Mil) to Dec. 2022 (€1,048 Mil) and increased from Dec. 2022 (€1,048 Mil) to Dec. 2023 (€1,052 Mil).


Gilead Sciences Other Gross PPE Historical Data

The historical data trend for Gilead Sciences's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gilead Sciences Other Gross PPE Chart

Gilead Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 724.50 743.09 842.52 1,047.84 1,051.80

Gilead Sciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,047.84 5,117.39 5,113.42 5,220.96 1,051.80

Gilead Sciences Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Gilead Sciences (MIL:1GILD) Business Description

Address
333 Lakeside Drive, Foster, CA, USA, 94404
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.

Gilead Sciences (MIL:1GILD) Headlines

No Headlines